pharmaphorum January 18, 2024
Phil Taylor

Apple has once again been prevented from selling two of its Apple Watch models in the US, in the latest phase of its patent dispute with health wearable company Masimo.

The tech giant stopped selling and importing versions of its Series 9 and Ultra 2 Apple Watches towards the end of last year over a complaint that the devices violated Masimo patents on the use of pulse oximetry sensors in wearables to measure blood oxygen levels.

It resumed sales as 2023 drew to a close after filing an emergency appeal against the ban, ordered by the International Trade Commission (ITC) in October, but a federal court has now ruled that the infringing devices must be taken off the market until...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Technology, Wearables
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
Wearable Device Can Warn of Worsening Heart Failure

Share This Article